Actively Recruiting
Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction
Led by Pharmicell Co., Ltd. · Updated on 2026-02-24
32
Participants Needed
4
Research Sites
263 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This phase II clinical trial with safety follow-up is designed to evaluate the efficacy and safety of Cellgram-ED (autologous bone marrow-derived mesenchymal stem cells) administered via intracavernous injection in patients with erectile dysfunction after radical prostatectomy.
CONDITIONS
Official Title
Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants who previously participated in the parent clinical trial and received the cell therapy (Cellgram-ED).
- Participants who have provided written informed consent to participate in this safety follow-up study.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Asan medical center
Seoul, South Korea
Actively Recruiting
2
Ewha womans university medical center
Seoul, South Korea
Actively Recruiting
3
Samsung medical center
Seoul, South Korea
Actively Recruiting
4
Seoul ST. Mary's hospital
Seoul, South Korea
Actively Recruiting
Research Team
D
daeun jung
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here